- Home
- News
- Articles+
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- News
- Articles
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
Cyril Amarchand Mangaldas Advised Geri Care Health Services On Investment Made By InvAscent

Cyril Amarchand Mangaldas Advised Geri Care Health Services on Investment Made by InvAscent
Cyril Amarchand Mangaldas advised Geri Care Health Services Private Limited, India’s first integrated geriatric health care brand, in relation to the INR 110 crores minority investment made by InvAscent, a healthcare and life sciences focused private equity investor.
Founded in 2018 by Dr. Lakshmipathy Ramesh, one of India’s foremost Geriatricians, Geri Care is India’s 1st elder-care service run by Geriatricians. It offers a comprehensive 360- degree continuum care for senior citizens, with a network of multi-speciality hospitals, assisted living centres, home care, and clinics, exclusively for senior citizens. Its path- breaking work over the past 5 years in Chennai has been recognized as one of the most effective models in providing holistic health care to the aged.
Geri Care proposes to utilize funds received from the transaction to expand its services beyond its headquarters in Chennai to other major cities in South India, including Bengaluru, Hyderabad, Cochin, and Coimbatore, and to establish centres of excellence in geriatric oncology, geriatric urology, geriatric cardiology, and ortho-geriatrics through its chain of multi-speciality hospitals for senior citizens.
The transaction team at CAM was led by KZ Kuriyan, Partner, with support from Aditi Aggarwal, Principal Associate; Nayonika Sinha, Associate; Varshini Prasad, Associate; Neha Giridharan, Associate; and Jvalita Krishan, Associate.
The team led by KZ Kuriyan, Partner, and Pooranimaa Hariharan, Partner, with support from Aditi Aggarwal, Principal Associate; Varshini Prasad, Associate; Neha Giridharan, Associate; and Jvalita Krishan, Associate, advised on the due diligence aspects of the deal.
The team led by Biplab Lenin, Partner, with support from Priyam Rajkumar, Senior Associate, and Anam Chowdhary, Associate, advised on the pharmaceutical and healthcare aspects of the deal.
Click to know more about the Cyril Amarchand Mangaldas